Gilead Sciences | GILD

Stock Price
142.89
Daily Change
0.94 0.66%
Monthly
20.79%
Yearly
45.24%
Q1 Forecast
137.58



Peers Price Chg Day Year Date
AbbVie 225.64 2.63 1.18% 18.67% Feb/02
Agios Pharmaceuticals 28.16 0.72 2.62% -16.23% Feb/02
ALKERMES 34.91 1.02 3.01% 13.49% Feb/02
Alnylam Pharmaceuticals 339.11 1.05 0.31% 23.51% Feb/02
Amgen 344.71 2.83 0.83% 19.33% Feb/02
Biogen 179.09 -0.80 -0.44% 25.82% Feb/02
BioMarin Pharmaceutical 57.95 1.41 2.49% -7.19% Feb/02
Bristol-Myers Squibb 55.89 0.84 1.53% -6.77% Feb/02
Gilead Sciences 142.89 0.94 0.66% 45.24% Feb/02
GlaxoSmithKline 1,925.00 48.50 2.58% 37.65% Feb/02

Indexes Price Day Year Date
US500 6997 37.41 0.54% 15.88% Feb/03
USND 23592 130.29 0.56% 21.66% Feb/02
US100 25867 186.22 0.73% 19.94% Feb/03

Gilead Sciences traded at $142.89 this Monday February 2nd, increasing $0.94 or 0.66 percent since the previous trading session. Looking back, over the last four weeks, Gilead Sciences gained 20.79 percent. Over the last 12 months, its price rose by 45.24 percent. Looking ahead, we forecast Gilead Sciences to be priced at 137.58 by the end of this quarter and at 125.25 in one year, according to Trading Economics global macro models projections and analysts expectations.

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company's portfolio of products and pipeline of investigational drugs includes treatments for HIV/acquired immune deficiency syndrome (AIDS), COVID-19, liver diseases, hematology/oncology/cell therapy and other. Its products for HIV/AIDS patients include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada and Atripla. It offers Veklury to patients with COVID-19. The Company's products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Viread and Vosevi. Its products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy and Zydelig. Other products include Letairis, Ranexa and AmBisome. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. The Company operates in more than 335 countries worldwide.



News Stream
Gilead Sciences Stock Price Hits All-time High
Gilead Sciences shares increased to an all-time high of 141.73 USD. Over the past 4 weeks, Gilead Sciences gained 15.33%, and in the last 12 months, it increased 45.64%.
2026-01-30
Gilead Sciences Stock Price Hits 4-week High
Gilead Sciences shares increased to 126.25 USD, the highest since December 2025. Over the past 4 weeks, Gilead Sciences gained 1.48%, and in the last 12 months, it increased 35.43%.
2026-01-21
Gilead Sciences Stock Price Hits 8-week Low
Gilead Sciences shares decreased to 118.07 USD, the lowest since November 2025. Over the past 4 weeks, Gilead Sciences lost 2.38%, and in the last 12 months, it increased 29.67%.
2026-01-05